Skip to main content
. 2021 Oct 20;9(10):e003353. doi: 10.1136/jitc-2021-003353

Table 1.

Comparison of the clinicopathological factors according to the HEV density

Parameter N=452 (%) Low HEV density High HEV density P value
n=226 (%) n=226 (%)
Sex 0.010
 Male 297 (65.7) 162 (71.7) 135 (59.7)
 Female 155 (34.3) 64 (28.3) 91 (40.3)
Age (years) 0.452
 <58 223 (49.3) 107 (47.3) 116 (51.3)
 ≥58 229 (50.7) 119 (52.7) 110 (48.7)
Histology 0.026
 WD/MD 172 (38.1) 98 (43.4) 74 (32.7)
 PD/SRC 280 (61.9) 128 (56.6) 152 (67.3)
Lauren type 0.019
 Intestinal 220 (48.7) 123 (54.4) 97 (42.9)
 Diffuse 232 (51.3) 103 (45.6) 129 (57.1)
Location 0.001
 Upper 85 (18.8) 38 (16.8) 47 (20.8)
 Mid 105 (23.2) 39 (17.3) 66 (29.2)
 Low 258 (57.1) 145 (64.2) 113 (50.0)
 Whole 4 (0.9) 4 (1.8) 0 (0)
T stage <0.001
 pT1 145 (32.1) 58 (25.7) 87 (38.5)
 pT2 59 (13.1) 27 (11.9) 32 (14.2)
 pT3 103 (22.8) 48 (21.2) 55 (24.3)
 pT4 145 (32.1) 93 (41.2) 52 (23.0)
N stage 0.001
 pN0 202 (44.7) 81 (35.8) 121 (53.5)
 pN1 71 (15.7) 42 (18.6) 29 (12.8)
 pN2 86 (19.0) 44 (19.5) 42 (18.6)
 pN3 93 (20.6) 59 (26.1) 34 (15.0)
TNM stage <0.001
 I 139 (30.8) 57 (25.2) 82 (36.3)
 II 144 (31.9) 64 (28.3) 80 (35.4)
 III 169 (37.4) 105 (46.5) 64 (28.3)
Crohn-like lymphoid reaction <0.001
 Score 0 75 (16.6) 59 (26.1) 16 (7.1)
 Score 1 203 (44.9) 112 (49.6) 91 (40.3)
 Score 2–3 174 (38.5) 55 (24.3) 119 (52.7)
Peritumoral lymphoid reaction 0.163
 Score 0 83 (18.4) 49 (21.7) 34 (15.0)
 Score 1 226 (50.0) 111 (49.1) 115 (50.9)
 Score 2–3 143 (31.6) 66 (29.2) 77 (34.1)
Intratumoral lymphoid reaction 0.016
 Score 0 29 (6.4) 21 (9.3) 8 (3.5)
 Score 1 304 (67.3) 154 (68.1) 150 (66.4)
 Score 2–3 119 (26.3) 51 (22.6) 68 (30.1)
Overall lymphoid reaction <0.001
 Score 0–2 97 (21.5) 69 (30.5) 28 (12.4)
 Score 3–6 313 (69.2) 147 (65.0) 166 (73.5)
 Score 7–9 42 (9.3) 10 (4.4) 32 (14.2)

HEV, high endothelial venule; MD, moderately differentiated; PD, poorly differentiated; SRC, signet ring cell; TNM, tumor, node, metastasis; WD, well differentiated.